Myasthenia Gravis

White arrow on a road pointing to the rising sun

Biotech

Dianthus' gMG asset blooms as phase 2 win sets up pivotal plans

Dianthus Therapeutics is advancing its challenge for the gMG market, outlining plans to move into phase 3 on the back of hits in a midphase study.

Nick Paul Taylor Sep 8, 2025 9:24am

Businessman climbing steps to pluck a star from the sky

Regeneron posts phase 3 win, advancing push to muscle in on gMG

Aug 26, 2025 9:41am

Graphic image of an arrow nailing the bullseye of a target

AstraZeneca's blockbuster contender hits phase 3 gMG goals

Jul 24, 2025 6:20am

A one dollar bill sitting next to a declining stock graph

Fierce Pharma

Vor Bio's surprise $4B revival deal splits investor reactions

Jun 26, 2025 10:55am

A photo finish at a horse race with both horses crossing the finish line

J&J links FcRn blocker to sustained benefits as FDA ruling nears

Apr 8, 2025 10:21am

relay

Immunovant posts phase 3 autoimmune win but won't seek approval

Mar 19, 2025 9:15am